Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

被引：25

作者：

Schjesvold, Fredrik ^{[1
,2
]}

Richardson, Paul G. ^{[3
]}

Facon, Thierry ^{[4
]}

Alegre, Adrian ^{[5
,6
]}

Spencer, Andrew ^{[7
]}

Jurczyszyn, Artur ^{[8
]}

Sunami, Kazutaka ^{[9
]}

Frenzel, Laurent ^{[10
]}

Min, Chang-Ki ^{[11
,12
]}

Guillonneau, Sophie ^{[13
]}

Lin, Peggy L. ^{[14
]}

Le-Guennec, Solenn ^{[15
]}

Campana, Frank ^{[16
]}

van de Velde, Helgi ^{[16
]}

Bensfia, Samira ^{[14
]}

Bringhen, Sara ^{[17
]}

机构：

[1] Oslo Univ Hosp, Oslo Myeloma Ctr, Oslo, Norway

[2] Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Oslo, Norway

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Lille Univ Hosp, Lille, France

[5] Hosp Univ La Princesa, Madrid, Spain

[6] Hosp Quironsalud, Madrid, Spain

[7] Monash Univ, Alfred Hlth, Dept Clin Hematol, Melbourne, Vic, Australia

[8] Jagiellonian Univ, Coll Med, Dept Hematol, Krakow, Poland

[9] Natl Hosp Org Okayama Med Ctr, Dept Hematol, Okayama, Japan

[10] Hop Necker Enfants Malad, Paris, France

[11] Catholic Hematol Hosp, Dept Hematol, Seoul, South Korea

[12] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Leukemia Res Inst, Seoul, South Korea

[13] Sanofi CMO, Chilly Mazarin, France

[14] Sanofi Global Oncol, Cambridge, MA USA

[15] Sanofi R&D, Vitry Sur Seine, France

[16] Sanofi R&D, Cambridge, MA USA

[17] Univ Torino, Azienda Osped Univ Citta Salute & Sci Torino, Myeloma Unit, Div Hematol, Turin, Italy

来源：

HAEMATOLOGICA | 2021年 / 106卷 / 04期

关键词：

SAR650984;

D O I：

10.3324/haematol.2020.253450

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1182 / 1187

页数：6

共 50 条

[31] Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis
Facon, Thierry
Moreau, Philippe
Martin, Thomas G.
Spicka, Ivan
Oriol, Albert
Koh, Youngil
Lim, Andrew
Mikala, Gabor
Rosinol, Laura
Yagci, Munci
Cavo, Michele
Yong, Kwee
Risse, Marie-Laure
Asset, Gaelle
Schwab, Sandrine
Martinez, Gracia
HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 1020 - 1029
[32] Isatuximab plus pomalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma in real life context in France: IMAGE subgroup analysis based on subgroups of interest
Decaux, Olivier
Fontan, Jean
Perrot, Aurore
Karlin, Lionel
Touzeau, Cyrille
Manier, Salomon
Belhadj, Karim
Trebouet, Adrien
Zunic, Patricia
Stoppa, Anne-Marie
Tekle, Christina
Gaucher, Marianne
Leleu, Xavier
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S194 - S195
[33] Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study (vol 394, pg 2096, 2019)
Attal, M.
Richardson, P. G.
Rajkumar, S., V
LANCET, 2019, 394 (10214): : 2072 - 2072
[34] Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis.
Facon, Thierry
Moreau, Philippe
Martin, Thomas G.
Spicka, Ivan
Oriol, Albert
Koh, Youngil
Lim, Andrew
Mikala, Gabor
Rosinol, Laura
Yagci, Munci
Cavo, Michele
Yong, Kwee
Risse, Marie-Laure
Asset, Gaelle
Schwab, Sandrine
Martinez, Gracia
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[35] Primary outcomes by 1q21+status for isatuximab-treated patients with relapsed/refractory multiple myeloma: subgroup analyses from ICARIA-MM and IKEMA
Martin, Tom
Richardson, Paul G.
Facon, Thierry
Moreau, Philippe
Perrot, Aurore
Spicka, Ivan
Bisht, Kamlesh
Inchauspe, Marlene
Casca, France
Mace, Sandrine
van de Velde, Helgi
Suzuki, Kenshi
HAEMATOLOGICA, 2022, 107 (10) : 2485 - 2491
[36] Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
Richardson, Paul G.
Perrot, Aurore
San Miguel, Jesus
Beksac, Meral
Spicka, Ivan
Leleu, Xavier
Schjesvold, Fredrik
Moreau, Philippe
Dimopoulos, Meletios A.
Huang, Shang-Yi
Minarik, Jiri
Cavo, Michele
Prince, H. Miles
Mace, Sandrine
Zhang, Rick
Dubin, Franck
Morisse, Mony Chenda
Anderson, Kenneth C.
REVISTA CHILENA DE LITERATURA, 2024, (109): : 2239 - 2249
[37] Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
Richardson, Paul G.
Perrot, Aurore
San Miguel, Jesus
Beksac, Meral
Spicka, Ivan
Leleu, Xavier
Schjesvold, Fredrik
Moreau, Philippe
Dimopoulos, Meletios A.
Huang, Shang-Yi
Minarik, Jiri
Cavo, Michele
Prince, H. Miles
Mace, Sandrine
Zhang, Rick
Dubin, Franck
Morisse, Mony Chenda
Anderson, Kenneth C.
HAEMATOLOGICA, 2024, 109 (07) : 2239 - 2249
[38] A phase 1b study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma
Mikhael, Joseph
Richardson, Paul
Usmani, Saad Z.
Raje, Noopur
Bensinger, William
Karanes, Chatchada
Campana, Frank
Kanagavel, Dheepak
Dubin, Franck
Liu, Qianying
Semiond, Dorothee
Anderson, Kenneth
BLOOD, 2019, 134 (02) : 123 - 133
[39] Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world: The retrospective IMAGE study
Decaux, Olivier
Fontan, Jean
Perrot, Aurore
Karlin, Lionel
Touzeau, Cyrille
Schulmann, Samantha
Manier, Salomon
Belhadj, Karim
Trebouet, Adrien
Zunic, Patricia
Schiano De Colella, Jean-Marc
Castel, Brice
van de Wyngaert, Zoe
Pica, Gian Matteo
Tiab, Mourad
Kuhnowski, Frederique
Bouketouche, Malek
Rigaudeau, Sophia
Benramdane, Riad
Tekle, Christina
Lafore, Radhia
Gaucher, Marianne
Corre, Jill
Leleu, Xavier
EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (03) : 290 - 297
[40] Pembrolizumab plus pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (KEYNOTE-183): subgroup analysis in Japanese patients
Matsumoto, Morio
Suzuki, Kenshi
Kuroda, Junya
Taniwaki, Masafumi
Sunami, Kazutaka
Kosugi, Hiroshi
Ando, Kiyoshi
Maruyama, Dai
Tobinai, Kensei
Kher, Uma
Farooqui, Mohammed
Liao, Jason
Marinello, Patricia
Matsuda, Kenji
Koh, Yasuhiro
Shimamoto, Takashi
Iida, Shinsuke
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (06) : 777 - 784

← 1 2 3 4 5 →